Medicine and Dentistry
Adalimumab
33%
Adiponectin
41%
Anaplastic Large Cell Lymphoma
50%
Angiofollicular Lymph Node Hyperplasia
50%
Antagonist
33%
Association
30%
ASXL1
90%
Blood Smear
50%
Carcinomatous Peritonitis
25%
Cell Proliferation
38%
Cells
49%
Chronic Myelogenous Leukemia
50%
Combination Therapy
54%
Diagnosis
71%
Diseases
44%
Distinct Entity
50%
Drive
58%
Follicular Dendritic Cells
40%
Gene
33%
Gene Rearrangement
50%
Gray Platelet Syndrome
50%
Hematologic Malignancy
33%
Immune Reconstitution Inflammatory Syndrome
50%
Innate Immunity
38%
Lactic Acid
25%
Leptin
50%
Leukemogenesis
50%
Leukocyte
56%
Lysine
50%
Mediator
26%
Monocyte
53%
Multiple Myeloma
38%
Myeloid Malignancy
100%
Nanoparticle
50%
Obesity
25%
Oxidized Low Density Lipoprotein
50%
Patient
56%
PHD Finger
50%
Polarization
50%
Prostate Cancer
50%
Proteasome Inhibitor
24%
Protein
54%
Pulmonary Cryptococcosis
33%
Secretion (Process)
31%
Therapeutic Procedure
41%
Thrombocytosis
50%
Trace Element
50%
Tuberous Sclerosis
50%
Tumor Necrosis Factor
85%
Ursolic Acid
50%
Pharmacology, Toxicology and Pharmaceutical Science
5 Amino 4 Imidazolecarboxamide Riboside
28%
Acetyl-CoA
11%
Adalimumab
33%
Adiponectin
44%
Aerosol
15%
Apoptosis
32%
Boronic Acid Derivative
11%
Bortezomib
11%
Carboxylase
11%
Carcinogenesis
7%
Carcinomatous Peritonitis
25%
Cell Proliferation
14%
Ceramide
25%
Clinical Trial
7%
Cyclic AMP Dependent Protein Kinase
22%
Deoxyribonucleoprotein
7%
Diseases
16%
Drug
28%
Drug Combination
50%
Drug Delivery
10%
Drug Delivery System
10%
Enalapril Maleate
7%
Fatty Acid
11%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
27%
Hypoxia Inducible Factor
28%
Immune Reconstitution Inflammatory Syndrome
50%
Infectious Complication
16%
Kidney Cancer
28%
Kidney Tumor
21%
Malignant Neoplasm
12%
Mammalian Target of Rapamycin Inhibitor
7%
Metabolic Syndrome X
16%
Mouse
7%
Mouse Model
7%
Multiple Myeloma
88%
Nanoparticle
50%
Neoplasm
14%
Nude Mouse
7%
Obesity
27%
Oxidized Low Density Lipoprotein
50%
Proteasome Inhibitor
22%
Prothrombin
21%
Pulmonary Cryptococcosis
33%
Renal Cell Carcinoma
14%
Survival
22%
Systemic Mycosis
16%
Transcription Factor
7%
Tumor Growth
12%
Tumor Necrosis Factor
33%
Vasculotropin
7%
